• About
  • Subscribe
  • Advertise
  • Contact
Friday, January 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Willcox recognised at home and abroad for innovative research

by rhiannon bowman
August 4, 2020
in Local, News, Optometry, Research
Reading Time: 3 mins read
A A
Professor Mark Willcox, director of research at UNSW School of Optometry and Vision Science.

Professor Mark Willcox, director of research at UNSW School of Optometry and Vision Science.

Share on FacebookShare on Twitter

Australian Professor Mark Willcox has been recognised for his research focusing on infection prevention and medical devices, receiving two awards from leading organisations nationally and overseas.

Willcox, a medical microbiologist and director of research at UNSW School of Optometry and Vision Science (SOVS), has been awarded the 2020 Donald R. Korb Award from the American Optometric Association (AOA) for research excellence.

He has also been awarded the National Health and Medical Research Council (NHMRC) Marshall and Warren Ideas Grant Award for the highest scoring Ideas Grant for 2019.

“I was very happy to receive the NHMRC Marshall and Warren Ideas Grant Award, especially as this is not the first time I’d applied for NHMRC funding for similar research. The success rate for the Ideas grants was only 11% this year, so I feel very privileged to have been awarded this grant,” Willcox said.

The Dr Donald R. Korb Award, bestowed by the Contact Lens and Cornea Section of the AOA, recognises an individual who has been an innovator and leader in the field of contact lenses and anterior segment disease.

“It is a great honour … Dr Korb is someone I hold in very high esteem, especially as he has been able to translate so much of his research and clinical knowledge to new products. I hope to emulate that with my research into antimicrobial surfaces and tear film biomarkers for ocular diseases such as dry eye,” Willcox said.

“I’m very motivated by translation of research into products. The progress from discovery to translation is very exciting. Not everything makes it through, but travelling along that course, whilst challenging, also produces new discoveries.”

Willcox’s laboratory at UNSW focuses on the development of novel antimicrobials that have applications as antibiotics and disinfectants.

According to a report from the SOVS, Willcox and his team develop new antimicrobial coatings that can be used for a variety of purposes, including coating of medical devices to reduce associated infections.

“Several of these initiatives have gone through to pre-clinical testing, and antimicrobial contact lenses through to Phase 3 clinical trials. Within the area of contact lens research, his laboratory focuses on understanding the aetiology of adverse events and comfort during contact lens wear,” the school stated.

Collaborative effort to overcome large-scale problem

Willcox’s research success is set to continue with the support of the NHMRC Ideas Grant, which will evaluate whether new antimicrobials that his team has patented can be bound to the surfaces of medical devices such as catheters and contact lenses and reduce the ability of microbes to adhere to them.

“My NHMRC grant is focussed primarily on producing new medical devices with antimicrobial functionality to tackle the very large issue of hospital acquired infections. However, the research came from studies we have been performing to produce an antimicrobial contact lens coating. We have run a Phase 3 clinical trial with the second iteration of our antimicrobial contact lens with colleagues in India, and showed a 50% reduction in adverse events,” Willcox said.

He continued: “However, we found the coatings only lasted for about seven days – so this NHMRC research is looking at mimics of those contact lens coatings that can be coated onto medical devices including contact lenses and last for much longer – a month for contact lenses, up to a year for other medical devices.”

The team will investigate the mechanism of action of the compounds and then test the ability of the best performing ones to control infections.

Willcox thanked those who helped put the winning grant together. “It involved people from Australia, the US and Singapore. A truly collaborative team to tackle a huge but often neglected worldwide problem.”

His Ideas Grant entitled ‘Tackling Hospital Acquired Infections with Peptide Mimics’ is in collaboration with Professor Naresh Kumar and Dr Renxun Chen (School of Chemistry UNSW), Professor Cyrille Boyer and Dr Edgar Wong (School of Chemical Engineering, UNSW), Professor David McKenzie (School of Physics, University of Sydney), Associate Professor Natalka Suchowerska (Chris O’Brien Lifehouse, University of Sydney) and Associate Professor Karen Vickery (Macquarie University).

Tags: American Optometric AssociationAOADonald R. Korb AwardIdeas Grant AwardNHMRCProfessor Mark WillcoxUNSW School of optometry and vision science

Related Posts

The study concluded that clinicians should be aware of how cognitive limitations can lead to a reliance on "decisional shortcuts" that might bias decision-making. Image: rh2010/stock.adobe.com

Study supports rethink of IOP threshold in glaucoma treatment

by Staff Writer
January 16, 2026

New research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...

optometrists cyber-crimes

Smart glasses market tipped to hit $200b by 2040

by Rob Mitchell
January 16, 2026

Financial analysts are predicting rapid growth of the smart glasses market, with one global eyewear giant predicted to potentially double...

Sophi is an eco-conscious phaco system. Image: Rayner.

FDA clears Rayner’s Sophi device for US market

by Staff Writer
January 15, 2026

British ophthalmic equipment manufacturer Rayner has secured US Food and Drug Administration (FDA) clearance for Sophi, its Swiss-engineered phacoemulsification system....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited